LATTICE MEDICAL

LATTICE MEDICAL is an implantable medical device company that develops and manufactures a breakthrough technology in the field of autologous fat reconstruction. The company has about 20 employees and a 3D printing production site dedicated to implantable medical devices.

The first application of its technology concerns breast reconstruction after cancer. One woman in eight is currently affected by breast cancer. In 40% of cases, the treatment is surgical with a complete or partial mastectomy. Only 20% of women will benefit from reconstruction because current techniques (breast implants or autologous surgical techniques) have drawbacks (cumbersome surgical procedure, multiple surgeries) and are costly for the health care system, which limits the number of reconstructions performed on patients. This is why LATTICE MEDICAL has developed the MATTISSE implantable medical device, which allows the regeneration of autologous fatty tissue and is completely resorbed from the body after breast reconstruction, thus avoiding additional surgeries and long-term sequelae and risks for patients.

Through its brand LATTICE SERVICES, the company commercializes medical grade filament for 3D printing, with several range of raw material, such as implantable PLGA, PDO or PLCL and non-implantable medical material such as PC, ABS, PET-G and TPE.

With a ISO 13845 3D printing farm in clean room, LATTICE SERVICES is able to help you in the design, prototype and production of your future medical device.